NCT03278600View on ClinicalTrials.gov

Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary

PHASE3CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

March 18, 2021

Study Completion Date

March 18, 2021

Conditions
Cancer of Unknown Primary Site
Interventions
GENETIC

tissue-of-origin (ORIGIN-PanCA○R) profiling

90-gene assay to predict the primary tumor site

Trial Locations (1)

200032

Fudan University Cancer Hospital, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03278600 - Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary | Biotech Hunter | Biotech Hunter